Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer

BACKGROUND. The systemic immune-inflammation index (SII), calculated using absolute platelet, neutrophil, and lymphocyte counts, has recently emerged as a predictor of survival for patients with pancreatic ductal adenocarcinoma (PDAC) when assessed at diagnosis. Neoadjuvant therapy (NAT) is increasi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Surg Oncol
Egile Nagusiak: Murthy, Pranav, Zenati, Mazen S., Al Abbas, Amr I., Rieser, Caroline J., Bahary, Nathan, Lotze, Michael T., Zeh, Herbert J., Zureikat, Amer H., Boone, Brian A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7879583/
https://ncbi.nlm.nih.gov/pubmed/31792715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-019-08094-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak